Drug Profile
DWJ 1261
Alternative Names: DWJ-1261Latest Information Update: 15 Mar 2019
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antithrombotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 15 Mar 2019 Discontinued - Preregistration for Thrombosis in South Korea (unspecified route)
- 30 Nov 2016 Phase-III for Thrombosis in South Korea (unspecified route)